Epigenetics, a new therapeutic target for fighting viral infections

被引:0
|
作者
Ahmad, Sandy Haider [1 ,2 ]
Assaf, Mona Diab [2 ]
Herbein, Georges [1 ,3 ]
机构
[1] Univ Bourgogne Franche Comte, Univ Franche Comte, UPRES EA4266, Dept Pathogens & Inflammat,EPILAB, 16 Route Gray, F-25030 Besancon, France
[2] Univ Libanaise, Beirut, Lebanon
[3] CHRU Besancon, Dept Virol, F-25030 Besancon, France
关键词
epigenetics; viral infection; therapeutic approaches; EPSTEIN-BARR-VIRUS; SARCOMA-ASSOCIATED HERPESVIRUS; HISTONE DEACETYLASE INHIBITORS; HUMAN CYTOMEGALOVIRUS HCMV; IMMEDIATE-EARLY PROMOTERS; TUMOR-SUPPRESSOR GENES; E-CADHERIN EXPRESSION; X PROTEIN; HIV-1; REPLICATION; CARCINOMA CELLS;
D O I
10.1684/vir.2021.0876
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Epigenetics play an important role in viral replication and in viral associated pathogenesis. In fact, viruses interact with epigenetic factors to promote the viral replication by stimulating the entry into the lytic cycle, but also by promoting viral latency. Furthermore, epigenetics control the immune response implemented by the host to counteract viral infections. Thus, epigenetic modifications are identified as potential therapeutic targets to control viral infections. Several studies have already shown the efficiency of inhibitors of histone deacetylases, demethylases, acetyltransferases and methyltransferases, as well as inhibitors of DNA methyltransferases in viral infections repression or in latency reactivation. In this review, we will examine the epigenetic regulation of viral infections by several DNA viruses, e.g. HSV, EBV, HCMV, KSHV, HBV, HPV and HAdV, and RNA viruses, e.g. HCV, HIV, IAV and CoV. Also, we will discuss the potential use of therapeutic approaches targeting epigenetics for the control of viral infections.
引用
收藏
页码:63 / 92
页数:30
相关论文
共 50 条
  • [1] EPHA2 Receptor as a Possible Therapeutic Target in Viral Infections
    Vincenzi, Marian
    Mercurio, Flavia Anna
    Leone, Marilisa
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (35) : 5670 - 5701
  • [2] Epigenetics as a Therapeutic Target in Osteoarthritis
    Nunez-Carro, Carmen
    Blanco-Blanco, Margarita
    Mariuxi Villagran-Andrade, Karla
    Blanco, Francisco J.
    de Andres, Maria C.
    PHARMACEUTICALS, 2023, 16 (02)
  • [3] Epigenetics as a Therapeutic Target in Breast Cancer
    Roisin Connolly
    Vered Stearns
    Journal of Mammary Gland Biology and Neoplasia, 2012, 17 : 191 - 204
  • [4] Epigenetics as a Therapeutic Target in Breast Cancer
    Connolly, Roisin
    Stearns, Vered
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2012, 17 (3-4) : 191 - 204
  • [5] Potential entry receptors for human γ-herpesvirus into epithelial cells: A plausible therapeutic target for viral infections
    Rani, Annu
    Jakhmola, Shweta
    Karnati, Srikanth
    Parmar, Hamendra Singh
    Jha, Hem Chandra
    TUMOUR VIRUS RESEARCH, 2021, 12
  • [6] Control of viral infections by epigenetic-targeted therapy
    Nehme, Zeina
    Pasquereau, Sebastien
    Herbein, Georges
    CLINICAL EPIGENETICS, 2019, 11 (1)
  • [7] Epigenetics of Virus-Induced Tumors: Perspectives for Therapeutic Targeting
    Vinokurova, Svetlana
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (32) : 4842 - 4861
  • [8] Epigenetics and depression: current challenges and new therapeutic options
    Schroeder, Marc
    Krebs, Marie O.
    Bleich, Stefan
    Frieling, Helge
    CURRENT OPINION IN PSYCHIATRY, 2010, 23 (06) : 588 - 592
  • [9] Epigenetics in Vascular Disease - Therapeutic Potential of New Agents
    Xu, Simon S.
    Alam, Saydul
    Margariti, Andriana
    CURRENT VASCULAR PHARMACOLOGY, 2014, 12 (01) : 77 - 86
  • [10] Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
    Claveria-Cabello, Alex
    Colyn, Leticia
    Arechederra, Maria
    Urman, Jesus M.
    Berasain, Carmen
    Avila, Matias A.
    Fernandez-Barrena, Maite G.
    CELLS, 2020, 9 (10) : 1 - 20